Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk
Journal of Digestive Diseases · 2023
DOI: 10.1111/1751-2980.13235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Xu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin Institute of Digestive Diseases, National Key Cl…. Hauptthemen laut MEDLINE: Colonoscopy, Colorectal Neoplasms. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Objectives
Currently, most colorectal neoplasia (CRN) screening strategies target asymptomatic individuals. However, studies on patients with non‐specific gastrointestinal symptoms (NSGS) are limited. We aimed to develop a CRN risk score specifically for patients with NSGS.
Methods
We prospectively enrolled patients who underwent initial colonoscopy between June 2020 and June 2021. A new risk scoring system was constructed and its applicability was evaluated.
Results
A total of 1522 consecutive patients were enrolled, among whom 1016 symptomatic patients were randomly divided into a training cohort and a validation cohort at a ratio of 7:3. The constructed Symptomatic Patients Colorectal Screening (SPCS) score showed higher diagnostic efficacy and sensitivity than several previous scoring systems. Using the SPCS score, the patients were divided into a low‐risk group (−2 to 3 points) and a high‐risk group (4–10 points) for CRN. Additionally, the detection rate of CRN in the training and validation cohorts of the high‐risk group were 41.7% and 37.0%, respectively. The SPCS score detected 79.3% (188/237) of CRN and 87.5% (42/48) of advanced CRN in the high‐risk group, which reduced the workload of colonoscopy to 45.9% (466/1016).
Conclusion
An effective CRN risk scoring system was established and validated for symptomatic patients, which accurately classified individuals into low‐risk and high‐risk groups for CRN and might be used to optimize colonoscopic resource allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Digestive Diseases, Department of Gastroenterology and Hepatology, Tianjin Institute of Digestive Diseases, National Key Clinical Specialty, General Hospital, Tianjin Medical University, Tianji…
- Graduate School of Tianjin Medical University, Tianjin, China.
- Department of Gastroenterology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, China.
ORCID-Profile: Xu Wang, Hai Long Cao
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Tianjin Key Medical Discipline (Specialty) Construction Project
- National Key Research and Development Program of China
Zitieren
APA
Wang, X., Zhang, X., Liu, J., Liu, T. Y., Wang, B. M., Liu, W. T., Xu, X., Zhang, J., & Cao, H. L. (2023). Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13235
Vancouver
Wang X, Zhang X, Liu J, Liu TY, Wang BM, Liu WT, et al. Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13235
BibTeX
@article{Wang2023,
author = {Wang, Xu and Zhang, Xi and Liu, Jiani and Liu, Tian Yu and Wang, Bang Mao and Liu, Wen Tian and Xu, Xin and Zhang, Jie and Cao, Hai Long},
title = {Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk},
journal = {Journal of Digestive Diseases},
year = {2023},
doi = {10.1111/1751-2980.13235}
}
EUVIMED